Price
$2.20+0.00%Social Signal Score
Analyst Ratings
4 analysts52-week range
- Last close
- $2.20
- Off 52w high
- -12.0%
- 200-day average
- $2.19
- vs 200-day
- +0.5%
Revenue
$719.4KCompany Profile
- CEO
- Vincent Amabile Jr.
- Sector
- Financial Services
- Industry
- Financial - Capital Markets
- Employees
- 5
- Beta
- 1.06
- Country
- US
- Piotroski score
- 6 / 9 (Middling)
- Altman Z-score
- -30.99
Financials
Revenue
$719.4K-63.7%Net Income
$102.4KEBITDA
$102.7KFree Cash Flow
—EPS (diluted)
$0.17Shares Outstanding (diluted)
600.1K+1686.5%Operating Expenses
$155.8KCash & Debt
$1.91MReturn of Capital
$0.00Revenue by Segment (annual)
$3.89MQuote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $2.32M | $-28.6K | $-0.05 |
| 2024 | $2.31M | $146.9K | $0.24 |
| 2023 | $2.14M | $-848.0K | $-1.41 |
| 2022 | $2.01M | $-949.0K | $-1.58 |
| 2021 | $2.97M | $-1.57M | $-2.62 |
| 2020 | $4.44M | $-1.43M | $-2.38 |
| 2019 | $9.25M | $-1.91M | $-3.42 |
| 2018 | $0.00 | $-55.7K | $-1.23 |
| 2017 | $0.00 | $-54.9K | $-1.63 |
| 2016 | $0.00 | $-56.7K | $-1.69 |
| 2015 | $0.00 | $-64.6K | $-1.92 |
| 2014 | $0.00 | $-106.3K | $-3.17 |
| 2013 | $0.00 | $-61.8K | $-1.84 |
| 2012 | $0.00 | $-143.0K | $-4.50 |
Valuation
MGHLhas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.
Signal Score (90d)
111+122.50%Social Signal Score
Mentions (100)
- Newsbusinesswire.com·16h ago·Neutral
Morgan Stanley Direct Lending Fund Announces Third Quarter 2026 Earnings Release and Conference Call NEW YORK--(BUSINESS WIRE)--Morgan Stanley Direct Lending Fund (NYSE: MSDL) ("MSDL”), a business development company externally managed by MS Capital Partners Adviser Inc., today announced it will release its financial results for the third quarter ended September 30, 2026, on Thursday, November 5, 2026, after the market closes. MSDL will host a conference call at 10:00 am ET on Friday, November 6
View source ↗ - Newsinvestopedia.com·19h ago·Neutral
SpaceX Stock Surges as Morgan Stanley Says Stock ‘Cheap and Getting Cheaper' Morgan Stanley sees SpaceX stock as “cheap and getting cheaper.” The opposite is happening today.
View source ↗ - Newsproactiveinvestors.com·21h ago·Positive
SpaceX shares rise as Morgan Stanley reiterates $300 target SpaceX Corp (NASDAQ:SPCX) shares rose 8% on Monday morning to $167.71 after Morgan Stanley (NYSE:MS) reiterated its 'overweight' rating and $300 price target, saying the stock remains undervalued on a growth-adjusted basis. Morgan Stanley (NYSE:MS) described SpaceX as “cheap and getting cheaper”, arguing that its valuation looks more attractive when expected growth is taken into account.
View source ↗ - Newsbarrons.com·21h ago·Positive
Wells Fargo Stock Rises as Morgan Stanley Sees Margin Pressure Easing Morgan Stanley upgraded Wells Fargo to Overweight, betting that easing margin pressure will support stronger earnings and returns.
View source ↗ - Newsbenzinga.com·22h ago·Neutral
SpaceX Is 'Cheap and Getting Cheaper' Morgan Stanley Says Morgan Stanley analyst Adam Jonas thinks investors are using the wrong yardstick to value SpaceX (NASDAQ:SPCX).
View source ↗ - News247wallst.com·22h ago·Positive
SpaceX Climbs 5% as Musk Renames SpaceXAI to SpaceXSI, Morgan Stanley Reiterates $300 Target; Rocket Lab Slips, AST SpaceMobile Nudges Higher A rebrand and a renewed show of Wall Street support are pushing SpaceX (NASDAQ:SPCX | SPCX Price Prediction) far past the rest of the space sector. SpaceX stock is up 5% to $166.71 in morning trading.
View source ↗ - Newsglobenewswire.com·1d ago·Neutral
Immix Biopharma to Participate in the 45th Annual J.P. Morgan Healthcare Conference LOS ANGELES, CA, Oct. 05, 2026 (GLOBE NEWSWIRE) -- Immix Biopharma, Inc. (“ImmixBio”, “Company”, “We” or “Us” or ”IMMX”), a global leader in AL Amyloidosis, today announced that it will present at the 45th Annual J.P. Morgan Healthcare Conference being held January 11-14, 2027 in San Francisco, CA.
View source ↗ - Newsbenzinga.com·1d ago·Positive
SpaceX Shares Look ‘Unusually Cheap,' Morgan Stanley Says: Elon Musk's AI, Starlink Bets Take Center Stage Investment bank Morgan Stanley analyst Adam Jonas reaffirmed bullish sentiment on Elon Musk-led Space Exploration Technologies Corp. (NASDAQ:SPCX), saying investors have a "unique opportunity" to buy shares that he considers "unusually cheap."
View source ↗ - Newsfinbold.com·3d ago·Neutral
Morgan Stanley sets Nvidia stock price target after naming it a ‘Top Pick' Seeing that Nvi d ia Corp. (NASDAQ: NVDA) stock soared to a new all-time high (ATH) on October 2, 2026, driven by its strong fundamentals such as its recently announced $150 billion share repurchase program, Joseph Moore, a Wall Street analyst at Morgan Stanley (NYSE: MS), has set his 12-month price target and named this company his ‘top pick' in the semiconductor industry.
View source ↗ - Newszacks.com·3d ago·Neutral
Will Higher Rates Boost Morgan Stanley's Wealth Management Growth? MS' Wealth Management growth could gain from higher rates, but deposit costs, lending demand and market pressure may temper the upside.
View source ↗ - News247wallst.com·4d ago·Positive
Morgan Stanley Just Bet Against Berkshire Hathaway's Favorite Homebuilder Morgan Stanley just issued a sell rating on a homebuilder that Berkshire Hathaway keeps buying in larger and larger quantities, and the reasoning behind each side reveals a fundamental disagreement about time, risk, and when housing recovers.
View source ↗ - Newsyoutube.com·4d ago·Neutral
Morgan Stanley Backs NVDA as Top Pick, Crude Oil & Yields Cool Friday's trading session is starting with some reprieve thanks to a tick lower in crude oil and Treasury yields. Tom White sets expectations for investors ahead of the opening bell.
View source ↗ - Newsbenzinga.com·4d ago·Neutral
Morgan Stanley Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call Morgan Stanley (NYSE:MS) will release its third-quarter earnings report before the opening bell on Wednesday, Oct. 14.
View source ↗ - Newsglobenewswire.com·5d ago·Neutral
Streamex Co-Founder Morgan Lekstrom to Transition to Independent Director Streamex Co-Founder Morgan Lekstrom transitions from Interim Executive Chairman to Independent Director, remaining on the Board and certain committees.
View source ↗ - Newskitco.com·5d ago·Positive
Gold price will break $5,000/oz in H2 2027, and silver's run to $120 was driven by more than hype – Morgan Stanley's Gower Gold prices may be under pressure at the moment, but ETF and central bank demand has stayed strong, and the yellow metal will be trading back above $5000 per ounce within a year, according to Amy Gower, head of metals and mining strategy at Morgan Stanley.In a recent interview with CNBC, Gower acknowledged that the current environment was a challenging one for gold.
View source ↗ - Newsmarketbeat.com·5d ago·Neutral
Kinder Morgan Sees $6B–$7B Growth Runway as Southeast Gas Demand Surges Kinder Morgan NYSE: KMI sees an opportunity-rich environment for midstream infrastructure as natural-gas demand from LNG exports, power generation and industrial growth supports a growing pipeline project pipeline, Chief Financial Officer David Michels said during a fireside chat.
View source ↗ - Newsproactiveinvestors.com·6d ago·Neutral
JP Morgan backs BAE and Babcock as defence investors favour durable order books JP Morgan has identified BAE Systems PLC (LSE:BA.) and Babcock International PLC (LSE:BAB) among European defence companies that it believes fit a preferred profile of long-duration order books and products that are difficult to substitute.
View source ↗ - Newsseekingalpha.com·7d ago·Neutral
Kinder Morgan: Buy This 4% Yield With $10 Billion Growth Backlog Kinder Morgan offers a compelling blend of income and growth, underpinned by fee-based cash flows and a $10.1 billion project backlog. KMI's natural gas focus, with volume growth and robust data center-driven demand, strengthens its multi-year growth outlook. Q2 2026 results showed 12% adjusted EBITDA and 32% adjusted EPS growth, supporting a well-covered 3.9% dividend yield and a BBB+ balance sheet.
View source ↗ - Newsmarketwatch.com·7d ago·Neutral
Morgan Stanley's Mike Wilson says an S&P 500 correction may be exactly what the market needs The chief U.S. equity strategist at the investment bank favors large-capitalization quality companies.
View source ↗ - Newsprnewswire.com·8d ago·Neutral
J.P. Morgan Taps Thunes to Streamline Global Payments: NYSE Content Update NYSE issues a pre-market daily advisory direct from the trading floor. NEW YORK, Sept.
View source ↗ - Newsprnewswire.com·11d ago·Neutral
Office of the President of the Republic of Paraguay and J.P. Morgan Asset Management Announce $200 Million Investment in Sustainable Forestry in Paraguay NEW YORK and ASUNCIÓN, Paraguay, Sept. 24, 2026 /PRNewswire/ -- At this week's Paraguay Investment Forum NYC 2026, the Office of the President of the Republic of Paraguay and J.P.
View source ↗ - Newsreuters.com·11d ago·Negative
Morgan Stanley Asia deals leaked in missent email attachment A senior Morgan Stanley banker covering financial sponsors in Asia accidentally leaked their deal pipeline in an email sent to clients, according to six people with knowledge of the matter.
View source ↗ - Newsyoutube.com·12d ago·Neutral
Meta AI Disrupts the Tech Race, Morgan Stanleys's Deal Leak Get a jump start on the US trading day with Dani Burger on "Bloomberg Open Interest." Diplomacy in New York raises hopes for an Iran breakthrough.
View source ↗ - Newsproactiveinvestors.com·13d ago·Neutral
JP Morgan upgrades BP, sees 25% upside on 'road to redemption' JP Morgan has turned more positive on BP PLC (LSE:BP.), upgrading the oil major to 'overweight' and lifting its price target by 20% to 675p, implying around 25% upside.
View source ↗ - Newsproactiveinvestors.com·14d ago·Neutral
Atalaya Mining gets the JP Morgan seal of approval Copper miner Atalaya Mining Copper (LSE:ATYM, TSX:AYM) has picked up a fresh cheerleader in the shape of JP Morgan, which has kicked off coverage with an "overweight" tag and a £13.30 price target. That implies roughly 30% upside, which is the sort of number that tends to get investors' attention.
View source ↗ - News247wallst.com·14d ago·Negative
SpaceX IPO'd at $1.8 Trillion, Crashed 32%, and Morgan Stanley Still Sees It Doubling SpaceX's historic IPO cratered by nearly a third, yet 28 Wall Street analysts refuse to downgrade it. The question is whether the bull case rests on transformative compounding or on contracts that expire in 90 days.
View source ↗ - Newsprnewswire.com·15d ago·Neutral
QIA and J.P. Morgan Asset Management Announce $20 Billion Strategic Partnership DOHA, Qatar and NEW YORK, Sept. 21, 2026 /PRNewswire/ -- (NYSE: JPM) Qatar Investment Authority (QIA) and J.P.
View source ↗ - Newsinvezz.com·15d ago·Neutral
Morgan Stanley warns of a 7% S&P 500 dip as rebound catalysts emerge The S&P 500 Index rose to 7,650 points on Monday as top technology stocks continued rising. It has jumped by 1.95% from its lowest level last week.
View source ↗ - Newsmarketbeat.com·15d ago·Negative
Recursion Pharmaceuticals Highlights AI Drug Platform, FAP Progress at Morgan Stanley Conference Recursion Pharmaceuticals NASDAQ: RXRX outlined its strategy, clinical pipeline and partnership progress at Morgan Stanley's Global Healthcare Conference, with CEO and President Najat Khan emphasizing the company's shift toward an end-to-end, AI-enabled drug discovery and development platform.
View source ↗ - Newsmarketbeat.com·15d ago·Positive
IDEXX Highlights Diagnostics Growth Drivers, Cancer Testing at Morgan Stanley Conference IDEXX Laboratories NASDAQ: IDXX executives reiterated the company's long-term growth framework at the Morgan Stanley Global Healthcare Conference, citing demand for veterinary diagnostics, product innovation, commercial investments and recurring-revenue economics as key drivers.
View source ↗ - Newsfool.com·17d ago·Neutral
SpaceX Stock Is Down 33% From Its High. Here's Why Morgan Stanley Thinks There's 106% Upside From Here. SpaceX stock corrected sharply following its blockbuster IPO. Morgan Stanley analysts just reiterated their $300 price target.
View source ↗ - Newsmarketbeat.com·18d ago·Positive
GE Aerospace Sees Soaring Engine Demand, $170B Services Backlog at Morgan Stanley Conference GE Aerospace NYSE: GE CFO Rahul Ghai said the company continues to see strong demand across commercial services, original equipment and defense programs, despite recent volatility in air traffic growth and persistent aerospace supply-chain constraints.
View source ↗ - News247wallst.com·18d ago·Positive
Tempus AI Is Ripping 30% Higher This Week After Morgan Stanley Boosts Revenue Outlook Tempus AI (NASDAQ:TEM | TEM Price Prediction) is having a breakout week after Morgan Stanley remarks on September 15 spotlighted fresh reimbursement-driven revenue lifts for the AI-powered diagnostics company. Shares have rallied 29.
View source ↗ - Newsnewsfilecorp.com·19d ago·Neutral
iMetal Resources Appoints Morgan Verge, P.Geo., to Lead Exploration New technical leadership follows the Company's $3.0 million private placement and board and management additions as iMetal advances Gowganda West Vancouver, British Columbia--(Newsfile Corp. - September 17, 2026) - iMetal Resources Inc. (TSXV: IMR) (OTCQB: IMRFF) (FSE: A7VA) ("iMetal" or the "Company") is pleased to announce that Morgan Verge, P.Geo., has been appointed Vice President, Exploration, effective immediately.
View source ↗ - Newsseekingalpha.com·19d ago·Positive
Odyssey Therapeutics, Inc. (ODTX) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript Odyssey Therapeutics, Inc. (ODTX) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
View source ↗ - Newsseekingalpha.com·19d ago·Positive
Sunbelt Rentals Holdings Inc. (SUNB) Presents at Morgan Stanley's 14th Annual Laguna Conference Transcript Sunbelt Rentals Holdings Inc. (SUNB) Presents at Morgan Stanley's 14th Annual Laguna Conference Transcript
View source ↗ - Newsseekingalpha.com·19d ago·Positive
Gubra A/S (GUBRF) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript Gubra A/S (GUBRF) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
View source ↗ - Newsseekingalpha.com·19d ago·Positive
Parabilis Medicines, Inc. (PBLS) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript Parabilis Medicines, Inc. (PBLS) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
View source ↗ - Newsseekingalpha.com·19d ago·Positive
Kinder Morgan: Riding The Natural Gas Boom Kinder Morgan offers robust dividend coverage, driven by record natural gas activity and a strong pipeline of organic growth projects. KMI benefits from 96% of cash flows being take-or-pay, fee-based, or hedged, providing high visibility and stability for future distributions. Natural gas demand, fueled by AI data center buildouts, positions KMI for accelerated EBITDA and distributable cash flow growth.
View source ↗ - Newsseekingalpha.com·19d ago·Positive
Zealand Pharma A/S (ZLDPY) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript Zealand Pharma A/S (ZLDPY) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
View source ↗ - Newsseekingalpha.com·19d ago·Positive
Karman Holdings Inc. (KRMN) Presents at Morgan Stanley's 14th Annual Laguna Conference Transcript Karman Holdings Inc. (KRMN) Presents at Morgan Stanley's 14th Annual Laguna Conference Transcript
View source ↗ - Newsbenzinga.com·19d ago·Positive
GE Vernova Stock Gains Following Bullish Executive Commentary at Morgan Stanley Conference Shares of GE Vernova Inc. (NYSE:GEV) are rising Wednesday afternoon as investors rally behind upbeat operational commentary from executive leadership at the 14th Annual Morgan Stanley Laguna Conference.
View source ↗ - Newsseekingalpha.com·19d ago·Positive
Attovia Therapeutics, Inc. (ATTO) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript Attovia Therapeutics, Inc. (ATTO) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
View source ↗ - Newsseekingalpha.com·19d ago·Positive
FTAI Aviation Ltd. (FTAI) Presents at Morgan Stanley's 14th Annual Laguna Conference Transcript FTAI Aviation Ltd. (FTAI) Presents at Morgan Stanley's 14th Annual Laguna Conference Transcript
View source ↗ - Newsseekingalpha.com·20d ago·Positive
Alamar Biosciences, Inc. (ALMR) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript Alamar Biosciences, Inc. (ALMR) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
View source ↗ - Newsmarketbeat.com·20d ago·Neutral
Morgan Stanley Sees Wealth, AI Financing and Deal Rebound Powering Growth Morgan Stanley NYSE: MS Co-President Dan Simkowitz said the firm does not view 2026 as a peak-earnings year, citing growth opportunities in wealth management, a developing capital-markets recovery and continued financing demand tied to artificial intelligence.
View source ↗ - Newsseekingalpha.com·20d ago·Positive
Shoulder Innovations, Inc. (SI) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript Shoulder Innovations, Inc. (SI) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
View source ↗ - Newsseekingalpha.com·20d ago·Positive
Lakefront Biotherapeutics NV (LKFT) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript Lakefront Biotherapeutics NV (LKFT) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
View source ↗ - Newsseekingalpha.com·20d ago·Positive
Eikon Therapeutics, Inc. (EIKN) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript Eikon Therapeutics, Inc. (EIKN) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
View source ↗ - Newsseekingalpha.com·20d ago·Positive
Ralliant Corporation (RAL) Presents at Morgan Stanley's 14th Annual Laguna Conference Transcript Ralliant Corporation (RAL) Presents at Morgan Stanley's 14th Annual Laguna Conference Transcript
View source ↗ - Newsseekingalpha.com·20d ago·Positive
Oxford Nanopore Technologies plc (OXFYY) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript Oxford Nanopore Technologies plc (OXFYY) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
View source ↗ - Newsseekingalpha.com·20d ago·Positive
Medline Inc. (MDLN) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript Medline Inc. (MDLN) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
View source ↗ - Newsseekingalpha.com·20d ago·Positive
Whitehawk Therapeutics, Inc. (WHWK) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript Whitehawk Therapeutics, Inc. (WHWK) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
View source ↗ - Newsseekingalpha.com·20d ago·Positive
Claritev Corporation (CTEV) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript Claritev Corporation (CTEV) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
View source ↗ - Newsseekingalpha.com·20d ago·Positive
Honeywell Aerospace Inc. (HONA) Presents at Morgan Stanley's 14th Annual Laguna Conference Transcript Honeywell Aerospace Inc. (HONA) Presents at Morgan Stanley's 14th Annual Laguna Conference Transcript
View source ↗ - Newsseekingalpha.com·21d ago·Negative
Morgan Stanley Direct Lending: 0.75x P/NAV, 12% Yield Not Enough To Pull The Trigger Morgan Stanley Direct Lending (MSDL) trades at a 0.75x P/NAV and yields more than 12%. But the BDC faces persistent portfolio and earnings headwinds. A recent joint venture failed to drive investment income growth, with Q2 net investment income declining to $0.45 and portfolio value shrinking. Rising non-accruals (2.9%), declining NAV, and tight dividend coverage signal deteriorating credit quality and heightene
View source ↗ - Newsseekingalpha.com·21d ago·Positive
BeOne Medicines AG (ONC) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript BeOne Medicines AG (ONC) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
View source ↗ - Newsseekingalpha.com·21d ago·Positive
Avalyn Pharma Inc. (AVLN) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript Avalyn Pharma Inc. (AVLN) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
View source ↗ - Newsseekingalpha.com·21d ago·Positive
GMR Solutions Inc. (GMRS) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript GMR Solutions Inc. (GMRS) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
View source ↗ - Newsseekingalpha.com·21d ago·Positive
Telix Pharmaceuticals Limited (TLX) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript Telix Pharmaceuticals Limited (TLX) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
View source ↗ - Newsfinbold.com·21d ago·Positive
Morgan Stanley is loading up on Bitcoin As Bitcoin (BTC) added more than $310 billion to its market capitalization over the past 30 days, reaching $1.57 trillion on September 14, Morgan Stanley (NYSE: MS) through its spot exchange-traded fund (ETF), Morgan Stanley Bitcoin Trust (MSBT), has been on a buying spree.
View source ↗ - Newsseekingalpha.com·21d ago·Positive
Generate Biomedicines, Inc. (GENB) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript Generate Biomedicines, Inc. (GENB) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
View source ↗ - Newsbusinesswire.com·22d ago·Neutral
Morgan Stanley Inclusive & Sustainable Ventures Announces 2026 Global Cohort of Innovators NEW YORK--(BUSINESS WIRE)--Morgan Stanley (NYSE: MS) today announced the 2026 global cohort of its Inclusive & Sustainable Ventures (MSISV). This year's cohort includes 20 startups and four nonprofits across the Americas and Europe, the Middle East and Africa (EMEA) participating in the firm's five-month accelerator program designed to help early-stage innovators develop and scale their impact. Selected fr
View source ↗ - Newsfoxbusiness.com·24d ago·Neutral
JP Morgan names Nelle Miller and William Sinclair co-CEOs of its US Private Bank Nelle Miller and William Sinclair take the helm of J.P. Morgan's U.S. Private Bank, overseeing $2.4 trillion in client assets across 57 offices.
View source ↗ - Newsbusinesswire.com·25d ago·Neutral
Charles River Laboratories to Present at Morgan Stanley and Baird Conferences WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River Laboratories to Present at Morgan Stanley and Baird Conferences.
View source ↗ - Newsproactiveinvestors.co.uk·25d ago·Neutral
JP Morgan tips IWG for 46% upside in "the real space race" JP Morgan has initiated coverage of IWG PLC (LSE:IWG), the world's largest flexible workspace provider, with an overweight rating and a December 2027 price target of 260p, implying 46% upside. The US bank argues flexible working has moved decisively into the mainstream, citing Savills data showing the proportion of flexible office space let to corporates has jumped from 13% in 2020 to 47% in 2025.
View source ↗ - News247wallst.com·25d ago·Positive
Morgan Stanley Sees 25% Meta Gain on AI Upside Meta shares have been on a tear lately, but the longer look is more sobering. The stock is up 9.97% over the past week and 9.59% over the past month, yet still sits down 1.
View source ↗ - Newsmarketbeat.com·26d ago·Neutral
Kinder Morgan Targets $1.4B in New Gas Projects as LNG, Power Demand Fuel Growth Kinder Morgan NYSE: KMI expects its natural gas business to remain its primary growth engine, supported by rising demand tied to liquefied natural gas exports and power generation, Chief Executive Officer Kim Dang said at a Barclays conference.
View source ↗ - Newsproactiveinvestors.co.uk·26d ago·Positive
Computacenter shares slide but JP Morgan sees more profit upside Computacenter PLC (LSE:CCC) offers a buying opportunity after a share price pullback defied earnings upgrades, according to JP Morgan, which sees scope for further forecast increases. In morning trading, the shares stood at 5,050p, down 3%, while the broker maintained its 'overweight' rating.
View source ↗ - Newsglobenewswire.com·26d ago·Neutral
Helus Pharma to Participate at the Morgan Stanley 24th Annual Global Healthcare Conference in New York CEO Michael Halstead to participate in a fireside chat on Wednesday, September 16, 2026 at 8:30 a.m. EDT. CEO Michael Halstead to participate in a fireside chat on Wednesday, September 16, 2026 at 8:30 a.m. EDT.
View source ↗ - Newsbusinesswire.com·26d ago·Neutral
Phibro Animal Health Corporation to Participate in Morgan Stanley Annual Global Healthcare Conference TEANECK, N.J.--(BUSINESS WIRE)--Phibro Animal Health Corporation (Nasdaq: PAHC) announced today it will participate in the Morgan Stanley Annual Global Healthcare Conference. President & Chief Executive Officer, Daniel Bendheim; Chief Operating Officer, Larry Miller; and Chief Financial Officer, Glenn David will address financial analysts and investors on Tuesday, September 15, 2026, at 1:05 PM
View source ↗ - Newsbusinesswire.com·26d ago·Neutral
Sunbelt Rentals to Attend the Morgan Stanley Laguna Conference on September 16, 2026 FORT MILL, S.C.--(BUSINESS WIRE)--Sunbelt Rentals Holdings, Inc. (NYSE: SUNB; LSE: SUNB) (“the Company”), a leader in the equipment rental industry, announced it will attend the 14th Annual Morgan Stanley Laguna Conference in Dana Point, California, on Wednesday, September 16, 2026. During the event, Brendan Horgan, chief executive officer, will participate in a fireside chat discussion. The fireside chat is sch
View source ↗ - Newsglobenewswire.com·26d ago·Negative
Oruka Therapeutics to Attend the 2026 Morgan Stanley Global Healthcare Conference MENLO PARK, Calif., Sept. 09, 2026 (GLOBE NEWSWIRE) -- Oruka Therapeutics, Inc. (“Oruka”) (Nasdaq: ORKA), a clinical-stage biotechnology company developing novel biologics designed to set a new standard for the treatment of chronic skin diseases including plaque psoriasis and hidradenitis suppurativa, today announced its attendance at the 2026 Morgan Stanley Global Healthcare Conference, taking place in New York, N
View source ↗ - Newsglobenewswire.com·26d ago·Neutral
Zealand Pharma to participate in the Morgan Stanley 24th Annual Global Healthcare Conference Press release – No. 15 / 2026 Zealand Pharma to participate in the Morgan Stanley 24th Annual Global Healthcare Conference Copenhagen, Denmark, September 9, 2026 - Zealand Pharma A/S (Nasdaq: ZEAL) (CVR-no.
View source ↗ - Newsglobenewswire.com·27d ago·Neutral
Tracy Robinson to Address Morgan Stanley's 14th Annual Laguna Conference on September 16 MONTREAL, Sept. 09, 2026 (GLOBE NEWSWIRE) -- Tracy Robinson, President and Chief Executive Officer of CN (TSX: CNR) (NYSE: CNI), will address the Morgan Stanley's 14th Annual Laguna Conference on September 16, 2026, starting at 10:00 a.m. Eastern Time.
View source ↗ - Newsproactiveinvestors.co.uk·27d ago·Positive
JP Morgan upgrades Kingspan on data centre momentum JP Morgan has upgraded Kingspan Group PLC (ISE:KRX), the Irish building materials group, to 'overweight' from 'neutral', citing strong earnings momentum from its data centre exposure that it believes is not fully reflected in the valuation. Order intake on data solutions for Kingspan's Advnsys segment has nearly quadrupled, yet the shares trade on 13 times 12-month forward EV/EBITDA, a discount of around 7% to their long-term average.
View source ↗ - Newsglobenewswire.com·27d ago·Neutral
Telix to Present at the Morgan Stanley 24th Annual Global Healthcare Conference and H.C. Wainwright 28th Annual Global Investment Conference MELBOURNE, Australia and INDIANAPOLIS, Sept. 09, 2026 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) advises that Dr. Christian Behrenbruch, Managing Director and Group CEO and Kevin Richardson, CEO, Precision Medicine will present at the upcoming Morgan Stanley 24th Annual Global Healthcare Conference and at the H.C. Wai
View source ↗ - Newsprnewswire.com·27d ago·Neutral
Stanley Black & Decker to Present at the Morgan Stanley 14th Annual Laguna Conference NEW BRITAIN, Conn., Sept. 8, 2026 /PRNewswire/ -- Stanley Black & Decker (NYSE: SWK) today announced that Chris Nelson, President & CEO, will speak at the Morgan Stanley 14th Annual Laguna Conference on Thursday, September 17, 2026 at 11:30 AM PT (2:30 PM ET).
View source ↗ - Newsglobenewswire.com·27d ago·Neutral
Lakefront to Present at the Morgan Stanley 24th Annual Global Healthcare Conference Mechelen, Belgium; 8 September 2026, 22.01 CET; Lakefront Biotherapeutics NV (Euronext & NASDAQ: LKFT) today announced that the Company will host a fireside chat at the Morgan Stanley 24th Annual Global Healthcare Conference in New York City at 5:35pm ET on Tuesday, September 15 th , 2026.
View source ↗ - Newsglobenewswire.com·27d ago·Neutral
Ascendis Pharma to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference COPENHAGEN, Denmark, Sept. 08, 2026 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced that company executives will participate in a fireside chat at the Morgan Stanley 24th Annual Global Healthcare Conference on Tuesday, September 15, 2026, at 8:30 a.m. Eastern Time / 5:30 a.m. Pacific Time in New York, New York.
View source ↗ - Newsmarketbeat.com·27d ago·Neutral
Morgan Stanley Eyes Good Things Ahead for Meta After $18 Billion Legal Settlement Meta Platforms NASDAQ: META just settled a legal headache that has cast a significant shadow over the firm and the stock. The company agreed to pay up to $18 billion over the course of a decade to end its youth social media addiction trial.
View source ↗ - Newsglobenewswire.com·28d ago·Neutral
CRISPR Therapeutics to Present at the Morgan Stanley 24th Annual Global Healthcare Conference ZUG, Switzerland and BOSTON, Sept. 08, 2026 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP) today announced that members of its senior management team will present at the Morgan Stanley 24th Annual Global Healthcare Conference on Monday, September 14, 2026 at 1:05 p.m.
View source ↗ - Newsproactiveinvestors.co.uk·28d ago·Positive
JP Morgan stays overweight on European banks, names NatWest a top pick JP Morgan has reiterated its 'overweight' rating on European banks, arguing the sector remains in what it calls a "perfect environment" for growth despite early signs of the interest rate cycle turning. Analyst Kian Abouhossein said the sector benefits from a "sweet spot" of European Central Bank rates between 2% and 3%, alongside lending momentum supported partly by artificial intelligence capital expenditure.
View source ↗ - Newsglobenewswire.com·28d ago·Neutral
Atea Pharmaceuticals to Present at the Morgan Stanley 24th Annual Global Healthcare Conference BOSTON, Sept. 08, 2026 (GLOBE NEWSWIRE) -- Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (Atea or Company), a late-stage clinical biopharmaceutical company engaged in the discovery and development of oral antiviral therapeutics for serious viral diseases, today announced that Jean-Pierre Sommadossi, PhD, Chief Executive Officer and Founder of Atea, together with other members of the Atea management team, w
View source ↗ - Newsproactiveinvestors.co.uk·28d ago·Negative
JP Morgan downgrades Bytes over AI lag as Computacenter leads pack Bytes Technology Group PLC (LSE:BYIT, FRA:9NY, JSE:BYI) received a less favourable call from JP Morgan on Monday, as the bank initiated coverage with an 'underweight' rating and named peer Computacenter PLC (LSE:CCC) its top pick in the European value-added reseller (VAR) sector. Shares in Bytes tumbled 2% to 414.40 on Monday, while Computacenter ticked higher to 5,615p, moves that came as JP Morgan set its 'underweight' rating o
View source ↗ - Newsglobenewswire.com·31d ago·Neutral
Integra LifeSciences to Present at the 2026 Wells Fargo Healthcare Conference and the 2026 Morgan Stanley Healthcare Conference PRINCETON, N.J., Sept. 04, 2026 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, today announced that Lea Knight, chief financial officer, and Michael McBreen, chief commercial officer, will present at the 2026 Wells Fargo Healthcare Conference on Wednesday, September 9, 2026, at 2:15 p.m. ET. Stu
View source ↗ - Newsbusinesswire.com·32d ago·Neutral
Tempus to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference CHICAGO--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM) today announced that Founder and CEO Eric Lefkofsky will participate in a fireside chat at the Morgan Stanley 24th Annual Global Healthcare Conference on Tuesday, September 15, 2026, at 8:30 a.m. ET in New York City.A live audio webcast of the conversation will be available here.About TempusTempus AI is a technology company advancing precision medicine thro
View source ↗ - Newsglobenewswire.com·32d ago·Neutral
Intellia Therapeutics to Present at Morgan Stanley 24th Annual Global Healthcare Conference CAMBRIDGE, Mass., Sept. 04, 2026 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (Nasdaq: NTLA), a leading biopharmaceutical company focused on revolutionizing medicine leveraging CRISPR gene editing and other core technologies, today announced that the company will present at the Morgan Stanley 24th Annual Global Healthcare Conference on Monday, September 14, 2026 at 4:05 p.m. ET.
View source ↗ - Newsglobenewswire.com·32d ago·Neutral
PacBio to Participate in the Morgan Stanley 24ᵗʰ Annual Global Healthcare Conference MENLO PARK, Calif., Sept. 03, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced today that management will participate in a fireside chat at the Morgan Stanley 24th Annual Global Healthcare Conference on Tuesday, September 15, 2026, at 4:50 PM ET in New York, New York.
View source ↗ - Newsprnewswire.com·32d ago·Neutral
CPKC President and CEO Keith Creel to address the Morgan Stanley 14th Annual Laguna Conference CALGARY, AB, Sept. 3, 2026 /PRNewswire/ -- Canadian Pacific Kansas City (TSX: CP) (NYSE: CP) (CPKC) President and Chief Executive Officer Keith Creel will address the Morgan Stanley 14th Annual Laguna Conference on Sept.
View source ↗ - Newsglobenewswire.com·33d ago·Neutral
Medline announces participation in the Morgan Stanley 24th Annual Global Healthcare Conference NORTHFIELD, Ill., Sept. 03, 2026 (GLOBE NEWSWIRE) -- Medline Inc. (“Medline”) (Nasdaq: MDLN) today announced that Jim Boyle, chief executive officer, and Mike Drazin, chief financial officer, are scheduled to present at the Morgan Stanley 24th Annual Global Healthcare Conference in New York, NY, on Tuesday, September 15, 2026, at 12:20pm ET.
View source ↗ - Newsglobenewswire.com·33d ago·Neutral
Weight Watchers to Participate in Morgan Stanley Annual Global Healthcare Conference NEW YORK, Sept. 03, 2026 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ: WW) (“Weight Watchers” or the “Company”), the global leader in science-backed weight management, today announced that the Company will be participating in the Morgan Stanley Annual Global Healthcare Conference on Tuesday, September 15th.
View source ↗ - Newsbusinesswire.com·33d ago·Neutral
Ralliant to Present at Morgan Stanley 14th Annual Laguna Conference RALEIGH, N.C.--(BUSINESS WIRE)--Ralliant Corporation (“Ralliant” or the “Company”) (NYSE: RAL) announced today that Tami Newcombe, President and Chief Executive Officer, will be presenting at Morgan Stanley's 14th Annual Laguna Conference on Tuesday, September 15, 2026 at 3:20 PM PT (6:20 PM ET). Access to the real-time audio webcast may be found on the Ralliant Investor Relations website at https://investors.ralliant.com, where
View source ↗ - Newsglobenewswire.com·33d ago·Positive
AVITA Medical to Participate in Lake Street Best Ideas Growth Conference and Morgan Stanley Healthcare Conference VALENCIA, Calif., Sept. 02, 2026 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a leading therapeutic acute wound care company delivering transformative solutions, today announced that its senior management will participate in the following investor conferences: Lake Street Capital Markets 10th Annual Best Ideas Growth (BIG10) Conference – Thursday, September 10, 2
View source ↗ - Newsglobenewswire.com·33d ago·Neutral
Arcutis Management to Present at the Morgan Stanley 24th Annual Global Healthcare Conference WESTLAKE VILLAGE, Calif., Sept. 02, 2026 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today announced that Arcutis management will present at the Morgan Stanley 24th Annual Global Healthcare Conference, taking place September 14-16, 2026, in New York.
View source ↗ - Newsprnewswire.com·33d ago·Neutral
J.P. Morgan Asset Management Announces Rebrand of Campbell Global to J.P. Morgan Natural Capital PORTLAND, Ore., Sept. 2, 2026 /PRNewswire/ -- J.P.
View source ↗ - News247wallst.com·33d ago·Negative
Nio Drops 4% on J.P. Morgan Downgrade and $4.50 Price Target, XPeng and Li Auto Slip Shares of Nio (NYSE:NIO | NIO Price Prediction) are down 4% to $3.92 in early Wednesday trading after J.P. Morgan cut the stock to Neutral from Overweight and lowered its price target to $4.50 from $7.00.
View source ↗ - Newscnbc.com·34d ago·Neutral
Meta settlement could clear the way for new AI product launches, Morgan Stanley says Meta's $18 billion trial settlement could see it accelerate the launch of new AI products. Analysts note that tech firms often unleash a wave of products after resolving substantial lawsuits.
View source ↗ - Newsprnewswire.com·34d ago·Neutral
Carrier to Present at Morgan Stanley's 14th Annual Laguna Conference PALM BEACH GARDENS, Fla., Sept. 1, 2026 /PRNewswire/ -- Carrier Global Corporation (NYSE: CARR) Chairman & CEO David Gitlin and Executive Vice President & CFO Patrick Goris will speak at the 14th Annual Morgan Stanley Conference on Tuesday, Sept.
View source ↗ - Newsprnewswire.com·34d ago·Neutral
Shoulder Innovations to Participate in the Morgan Stanley 24th Annual Healthcare Conference GRAND RAPIDS, Mich., Sept. 1, 2026 /PRNewswire/ -- Shoulder Innovations, Inc. (Shoulder Innovations, or the company) (NYSE: SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, today announced that members of management will participate in a fireside chat at the Morgan Stanley 24th Annual Healthcare Conference.
View source ↗
Insider trading
Open-market buys and sells by MGHL officers and directors.
- Bought
- $2k
- Sold
- $185.1m
3 trades
9 trades
- Carucci Claudia Bsold
- Carucci Claudia Bsold
- Carucci Claudia Bsold
- Carucci Claudia Bsold
- Carucci Claudia Bsold
- Carucci Claudia Bsold
- Carucci Walter P /nybought
- Carucci Walter P /nysold
9 further Form 4 entries are share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.
Congress trades
No disclosed congressional trades in MGHL.
Self-reported filings, amounts as brackets. Via Senate/House disclosures.
